DANIEL WEGG: Open Payments
NPI 1013909241 · WINCHESTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 6 payments from 4 companies in 2025. Trend: 2023 $202 · 2024 $222 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $46 |
| ABBVIE INC. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Ozempic, CAPLYTA, UBRELVY, JOURNAVX, VRAYLAR.
Industry payments across IN — which companies pay providers there.
